Neurobiology of Aging
Volume 30, Issue 11 , Pages 1756-1776 , November 2009

Synaptic contact number and size in stratum radiatum CA1 of APP/PS1ΔE9 transgenic mice

  • Mark J. West

      Affiliations

    • Anatomical Institute, University of Aarhus, Aarhus, Denmark
    • Corresponding Author InformationCorresponding author at: Institute of Anatomy, Building 1234, University Park, 8000 Aarhus C, Denmark. Tel.: +45 8942 3011; fax: +45 8942 3060.
    • ,
  • Georg Bach

      Affiliations

    • Anatomical Institute, University of Aarhus, Aarhus, Denmark
    • ,
  • Andreas Søderman

      Affiliations

    • Anatomical Institute, University of Aarhus, Aarhus, Denmark
    • ,
  • Jens Ledet Jensen

      Affiliations

    • Department of Theoretical Statistics, University of Aarhus, Aarhus, Denmark

Received 29 August 2007 ,Revised 11 January 2008 ,Accepted 18 January 2008.

References 

  1. Almeida CG, Tampellini D, Takahashi RH, Greengard P, Lin MT, Snyder EM, et al. Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses. Neurobiol. Dis. 2005;20(2):187–198
  2. Ashley J, Packard M, Ataman B, Budnik V. Fasciclin II signals new synapse formation through amyloid precursor protein and the scaffolding protein dX11/Mint. J. Neurosci. 2005;25(25):5943–5955
  3. Barndorff-Nielsen O. Exponentially decreasing distributions for the logarithm of particle size. Proc. Roy. Soc. Lond. A. 1977;353:401–419
  4. Bell KFS, Cuello AC. Altered synaptic function in Alzheimers disease. Eur. J. Pharmacol. 2006;545:11–21
  5. Blæsild, P., Sørensen, M.K., 1992. Letter to Anonymous.
  6. Blanchard V, Moussaoui S, Czech C, Touchet N, Bonici B, Planche M, et al. Time sequence of maturation of dystrophic neurites associated with Abeta deposits in APP/PS1 transgenic mice. Exp. Neurol. 2003;184(1):247–263
  7. Boncristiano S, Calhoun ME, Howard V, Bondolfi L, Kaeser SA, Wiederhold KH, et al. Neocortical synaptic bouton number is maintained despite robust amyloid deposition in APP23 transgenic mice. Neurobiol. Aging. 2005;26(5):607–613
  8. Borchelt DR, Thinakaran G, Eckman CB, Lee MK, Davenport F, Ratovitsky T, et al. Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1–42/1–40 ratio in vitro and in vivo. Neuron. 1996;17(5):1005–1013
  9. Casas C, Sergeant N, Itier JM, Blanchard V, Wirths O, van der KN, et al. Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Abeta42 accumulation in a novel Alzheimer transgenic model. Am. J. Pathol. 2004;165(4):1289–1300
  10. Cirrito JR, Yamada KA, Finn MB, Sloviter RS, Bales KR, May PC, et al. Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. Neuron. 2005;48(6):913–922
  11. Coleman P, Federoff H, Kurlan R. A focus on the synapse for neuroprotection in Alzheimer disease and other dementias. Neurology. 2004;63(7):1155–1162
  12. Coleman PD, Yao PJ. Synaptic slaughter in Alzheimer's disease. Neurobiol. Aging. 2003;24(8):1023–1027
  13. Cruz-Orive LM. A general variance predictor for Cavalieri slices. J. Microsc. 2006;222(Pt 3):158–165
  14. DeGroot DMG. Comparison of methods for estimation of the thickness of ultrathin tissue sections. J. Microsc. 1988;151:23–42
  15. Dickey CA, Loring JF, Montgomery J, Gordon MN, Eastman PS, Morgan D. Selectively reduced expression of synaptic plasticity-related genes in amyloid precursor protein+presenilin-1 transgenic mice. J. Neurosci. 2003;23(12):5219–5226
  16. Dickson DW. Building a more perfect beast: APP transgenic mice with neuronal loss. Am. J. Pathol. 2004;164(4):1143–1146
  17. Dong H, Martin MV, Chambers S, Csernansky JG. Spatial relationship between synapse loss and beta-amyloid deposition in Tg2576 mice. J. Comp. Neurol. 2007;500(2):311–321
  18. Ertekin-Taner N, Ronald J, Feuk L, Prince J, Tucker M, Younkin L, et al. Elevated amyloid beta protein (Abeta42) and late onset Alzheimer's disease are associated with single nucleotide polymorphisms in the urokinase-type plasminogen activator gene. Hum. Mol. Genet. 2005;14(3):447–460
  19. Ferreiro E, Resende R, Costa R, Oliveira CR, Pereira CM. An endoplasmic-reticulum-specific apoptotic pathway is involved in prion and amyloid-beta peptides neurotoxicity. Neurobiol. Dis. 2006;23(3):669–678
  20. Fiala JC, Harris KM. Cylindrical diameters method for calibrating section thickness in serial electron microscopy. J. Microsc. 2001;202(Pt 3):468–472
  21. Fiala JC, Harris KM. Extending unbiased stereology of brain ultrastructure to three-dimensional volumes. J. Am. Med. Inform. Assoc. 2001;8(1):1–16
  22. Forero DA, Casadesus G, Perry G, Arboleda H. Synaptic dysfunction and oxidative stress in Alzheimer's disease: emerging mechanisms. J. Cell. Mol. Med. 2006;10(3):796–805
  23. Ganeshina O, Berry RW, Petralia RS, Nicholson DA, Geinisman Y. Differences in the expression of AMPA and NMDA receptors between axospinous perforated and nonperforated synapses are related to the configuration and size of postsynaptic densities. J. Comp. Neurol. 2004;468(1):86–95
  24. Ganeshina O, Berry RW, Petralia RS, Nicholson DA, Geinisman Y. Synapses with a segmented, completely partitioned postsynaptic density express more AMPA receptors than other axospinous synaptic junctions. Neuroscience. 2004;125(3):615–623
  25. Geinisman Y, Ganeshina O, Yoshida R, Berry RW, Disteroft JF, Gallager M. Aging, spatial learning, and total synapse number in the rat CA1 stratum radiatum. Neurobiol. Aging. 2007;25:407–416
  26. Geinisman Y, Gundersen HJ, van der ZE, West MJ. Unbiased stereological estimation of the total number of synapses in a brain region. J. Neurocytol. 1996;25(12):805–819
  27. Glabe CG. Common mechanisms of amyloid oligomer pathogenesis in degenerative disease. Neurobiol. Aging. 2006;27(4):570–575
  28. Graff-Radford NR, Crook JE, Lucas J, Boeve BF, Knopman DS, Ivnik RJ, et al. Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease. Arch. Neurol. 2007;64(3):354–362
  29. Grutzendler J, Helmin K, Tsai J, Gan WB. Various dendritic abnormalities are associated with fibrillar amyloid deposits in Alzheimer's disease. Ann. NY Acad. Sci. 2007;1097:30–39
  30. Gundersen HJ. Stereology of arbitrary particles. A review of unbiased number and size estimators and the presentation of some new ones. J. Microsc. 1986;143:3–45
  31. Gundersen HJ, Jensen EB, Kieu K, Nielsen J. The efficiency of systematic sampling in stereology—reconsidered. J. Microsc. 1999;193(Pt 3):199–211
  32. Haass C, Selkoe DJ. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat. Rev. Mol. Cell. Biol. 2007;8(2):101–112
  33. Hardy JA, Higgins GA. Alzheimer's disease: the amyloid cascade hypothesis. Science. 1992;256(5054):184–185
  34. Harris KM, Perry E, Bourne J, Feinberg M, Ostroff L, Hurlburt J. Uniform serial sectioning for transmission electron microscopy. J. Neurosci. 2006;26(47):12101–12103
  35. Hayat MA. Principles and Techniques of Electron Microscopy, Biological Applications. New York: Van Nostrand Reinhold; 1970;
  36. Herard AS, Besret L, Dubois A, Dauguet J, Delzescaux T, Hantraye P, et al. siRNA targeted against amyloid precursor protein impairs synaptic activity in vivo. Neurobiol. Aging. 2006;27(12):1740–1750
  37. Hsia AY, Masliah E, McConlogue L, Yu GQ, Tatsuno G, Hu K, et al. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc. Natl. Acad. Sci. U.S.A. 1999;96(6):3228–3233
  38. Hsieh H, Boehm J, Sato C, Iwatsubo T, Tomita T, Sisodia S, et al. AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss. Neuron. 2006;52(5):831–843
  39. Iacono, D., O’Brian, R., Resnik, S.M., Zonderman, A.B., Pletnikova, O., Rudow, G., West, M.J., Crain, B., Troncoso, J., submitted for publication. Neuronal hypertrophy in asymptomatic Alzheimer's disease.
  40. Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, Ihara Y. Visualization of Abeta42(43) and Abeta40 in senile plaques with end-specific Abeta monoclonals: evidence that an initially deposited species is Abeta 42(43). Neuron. 1994;13:45–53
  41. Jacobsen JS, Wu CC, Redwine JM, Comery TA, Arias R, Bowlby M, et al. Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 2006;103(13):5161–5166
  42. Jankowsky JL, Fadale DJ, Anderson J, Xu GM, Gonzales V, Jenkins NA, et al. Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum. Mol. Genet. 2004;13(2):159–170
  43. Jankowsky JL, Slunt HH, Ratovitski T, Jenkins NA, Copeland NG, Borchelt DR. Co-expression of multiple transgenes in mouse CNS: a comparison of strategies. Biomol. Eng. 2001;17(6):157–165
  44. Kamenetz F, Tomita T, Hsieh H, Seabrook G, Borchelt D, Iwatsubo T, et al. APP processing and synaptic function. Neuron. 2003;37(6):925–937
  45. Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW, et al. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science. 2003;300(5618):486–489
  46. Kelly BL, Ferreira A. Beta-amyloid disrupted synaptic vesicle endocytosis in cultured hippocampal neurons. Neuroscience. 2007;147:60–70
  47. Kim J, Onstead L, Randle S, Price R, Smithson L, Zwizinski C, et al. Abeta40 inhibits amyloid deposition in vivo. J. Neurosci. 2007;27(3):627–633
  48. Lacor PN, Buniel MC, Furlow PW, Clemente AS, Velasco PT, Wood M, et al. Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. J. Neurosci. 2007;27(4):796–807
  49. Lesne S, Koh MT, Kotilinek L, Kayed R, Glabe CG, Yang A, et al. A specific amyloid-beta protein assembly in the brain impairs memory. Nature. 2006;440(7082):352–357
  50. Machova E, Jakubik J, Michal P, Oksman M, Iivonen H, Tanila H, et al. Impairment of muscarinic transmission in transgenic APPswe/PS1dE9 mice. Neurobiol. Aging. 2006;
  51. Marchesi VT. An alternative interpretation of the amyloid Abeta hypothesis with regard to the pathogenesis of Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 2005;102(26):9093–9098
  52. Masliah E, Crews L, Hansen L. Synaptic remodeling during aging and in Alzheimer's disease. J. Alzheimers Dis. 2006;9(3 Suppl.):91–99
  53. Masliah E, Sisk A, Mallory M, Mucke L, Schenk D, Games D. Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein and Alzheimer's disease. J. Neurosci. 1996;16(18):5795–5811
  54. Masliah E, Westland CE, Rockenstein EM, Abraham CR, Mallory M, Veinberg I, et al. Amyloid precursor proteins protect neurons of transgenic mice against acute and chronic excitotoxic injuries in vivo. Neuroscience. 1997;78(1):135–146
  55. Mattfeldt T. Editorial introduction to papers. J. Microsc. 2006;222:143–145
  56. Mattfeldt T. Prediction of the variance of stereological volume estimates from systematic sections using computer-intensive methods. J. Microsc. 2006;222(Pt 3):166–176
  57. Mattson MP. Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol. Rev. 1997;77(4):1081–1132
  58. McGowan E, Eriksen J, Hutton M. A decade of modeling Alzheimer's disease in transgenic mice. Trends Genet. 2006;22(5):281–289
  59. Micheva KD, Smith SJ. Array tomography: a new tool for imaging the molecular architecture and ultrastructure of neural circuits. Neuron. 2007;55(1):25–36
  60. Moolman DL, Vitolo OV, Vonsattel JP, Shelanski ML. Dendrite and dendritic spine alterations in Alzheimer models. J. Neurocytol. 2004;33(3):377–387
  61. Mucke L, Masliah E, Johnson WB, Ruppe MD, Alford M, Rockenstein EM, et al. Synaptotrophic effects of human amyloid beta protein precursors in the cortex of transgenic mice.. Brain Res. 1994;666(2):151–167
  62. Mucke L, Masliah E, Yu GQ, Mallory M, Rockenstein EM, Tatsuno G, et al. High-level neuronal expression of abeta 1–42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J. Neurosci. 2000;20(11):4050–4058
  63. Naruse S, Thinakaran G, Luo JJ, Kusiak JW, Tomita T, Iwatsubo T, et al. Effects of PS1 deficiency on membrane protein trafficking in neurons. Neuron. 1998;21(5):1213–1221
  64. Nicholson DA, Yoshida R, Berry RW, Gallagher M, Geinisman Y. Reduction in size of perforated postsynaptic densities in hippocampal axospinous synapses and age-related spatial learning impairments. J. Neurosci. 2004;24(35):7648–7653
  65. Nyengaard JR, Gundersen HJ. Direct and efficient stereological estimation of total cell quantities using electron microscopy. J. Microsc. 2006;222(Pt 3):182–187
  66. Oddo S, Caccamo A, Smith IF, Green KN, LaFerla FM. A dynamic relationship between intracellular and extracellular pools of Abeta. Am. J. Pathol. 2006;168(1):184–194
  67. Oh ES, Savonenko AV, King JF, Tucker SMF, Rudow GL, Xu G, et al. Amyloid precurser protein increases cortical neuron size in transgenic mice. Neurobiol. Aging. 2009;30:1238–1244
  68. Palop JJ, Chin J, Bien-Ly N, Massaro C, Yeung BZ, Yu GQ, et al. Vulnerability of dentate granule cells to disruption of arc expression in human amyloid precursor protein transgenic mice. J. Neurosci. 2005;25(42):9686–9693
  69. Palop JJ, Chin J, Mucke L. A network dysfunction perspective on neurodegenerative diseases. Nature. 2006;443(7113):768–773
  70. Perez SE, Lazarov O, Koprich JB, Chen EY, Rodriguez-Menendez V, Lipton JW, et al. Nigrostriatal dysfunction in familial Alzheimer's disease-linked APPswe/PS1DeltaE9 transgenic mice. J. Neurosci. 2005;25(44):10220–10229
  71. Priller C, Dewachter I, Vassallo N, Paluch S, Pace C, Kretzschmar HA, et al. Mutant presenilin 1 alters synaptic transmission in cultured hippocampal neurons. J. Biol. Chem. 2007;282(2):1119–1127
  72. Redwine JM, Kosofsky B, Jacobs RE, Games D, Reilly JF, Morrison JH, et al. Dentate gyrus volume is reduced before onset of plaque formation in PDAPP mice: a magnetic resonance microscopy and stereologic analysis. Proc. Natl. Acad. Sci. U.S.A. 2003;100(3):1381–1386
  73. Roch JM, Masliah E, Roch-Levecq AC, Sundsmo MP, Otero DA, Veinbergs I, et al. Increase of synaptic density and memory retention by a peptide representing the trophic domain of the amyloid beta/A4 protein precursor. Proc. Natl. Acad. Sci. U.S.A. 1994;91(16):7450–7454
  74. Roher AE, Lowenson JD, Clarke S, Wolkow C, Wang R, Cotter RJ, et al. Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease. J. Biol. Chem. 1993;268(5):3072–3083
  75. Roselli F, Tirard M, Lu J, Hutzler P, Lamberti P, Livrea P, et al. Soluble beta-amyloid1-40 induces NMDA-dependent degradation of postsynaptic density-95 at glutamatergic synapses. J. Neurosci. 2005;25(48):11061–11070
  76. Rutten BP, Van der Kolk NM, Schafer S, van Zandvoort MA, Bayer TA, Steinbusch HW, et al. Age-related loss of synaptophysin immunoreactive presynaptic boutons within the hippocampus of APP751SL, PS1M146L, and APP751SL/PS1M146L transgenic mice. Am. J. Pathol. 2005;167(1):161–173
  77. Saido TC, Iwata N. Metabolism of amyloid beta peptide and pathogenesis of Alzheimer's disease. Towards presymptomatic diagnosis, prevention and therapy. Neurosci. Res. 2006;54(4):235–253
  78. Salehi A, Delcroix JD, Belichenko PV, Zhan K, Wu C, Valletta JS, et al. Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration. Neuron. 2006;51(1):29–42
  79. Scheff SW, Price DA. Synaptic pathology in Alzheimer's disease: a review of ultrastructural studies. Neurobiol. Aging. 2003;24(8):1029–1046
  80. Scheff SW, Price DA, Schmitt FA, DeKosky ST, Mufson EJ. Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment. Neurology. 2007;68(18):1501–1508
  81. Scheff SW, Price DA, Schmitt FA, Mufson EJ. Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment. Neurobiol. Aging. 2006;27(10):1372–1384
  82. Schmitz C, Rutten BP, Pielen A, Schafer S, Wirths O, Tremp G, et al. Hippocampal neuron loss exceeds amyloid plaque load in a transgenic mouse model of Alzheimer's disease. Am. J. Pathol. 2004;164(4):1495–1502
  83. Selkoe DJ. Alzheimer's disease is a synaptic failure. Science. 2002;298(5594):789–791
  84. Shen J, Kelleher RJ. The presenilin hypothesis of Alzheimer's disease: evidence for a loss-of-function pathogenic mechanism. Proc. Natl. Acad. Sci. U.S.A. 2007;104(2):403–409
  85. Shoji M, Kanai M. Cerebrospinal fluid Abeta40 and Abeta42: natural course and clinical usefulness. J. Alzheimers Dis. 2001;3(3):313–321
  86. Sizova D, Charbaut E, Delalande F, Poirier F, High AA, Parker F, et al. Proteomic analysis of brain tissue from an Alzheimer's disease mouse model by two-dimensional difference gel electrophoresis. Neurobiol. Aging. 2007;28(3):357–370
  87. Slomianka L, West MJ. Estimators of the precision of stereological estimates: an example based on the CA1 pyramidal cell layer of rats. Neuroscience. 2005;136(3):757–767
  88. Smith IF, Green KN, LaFerla FM. Calcium dysregulation in Alzheimer's disease: recent advances gained from genetically modified animals. Cell Calcium. 2005;38(3/4):427–437
  89. Snyder EM, Nong Y, Almeida CG, Paul S, Moran T, Choi EY, et al. Regulation of NMD A receptor trafficking by amyloid-beta. Nat. Neurosci. 2005;8(8):1051–1058
  90. Spires TL, Hyman BT. Transgenic models of Alzheimer's disease: learning from animals. NeuroRx. 2005;2(3):423–437
  91. Spires TL, Meyer-Luehmann M, Stern EA, McLean PJ, Skoch J, Nguyen PT, et al. Dendritic spine abnormalities in amyloid precursor protein transgenic mice demonstrated by gene transfer and intravital multiphoton microscopy. J. Neurosci. 2005;25(31):7278–7287
  92. Stein TD, Johnson JA. Lack of neurodegeneration in transgenic mice overexpressing mutant amyloid precursor protein is associated with increased levels of transthyretin and the activation of cell survival pathways. J. Neurosci. 2002;22(17):7380–7388
  93. Stokin GB, Lillo C, Falzone TL, Brusch RG, Rockenstein E, Mount SL, et al. Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science. 2005;307(5713):1282–1288
  94. Sultana R, Boyd-Kimball D, Cai J, Pierce WM, Klein JB, Merchant M, et al. Proteomics analysis of the Alzheimer's disease hippocampal proteome. J. Alzheimer's Dis. 2007;11:153–164
  95. Takeuchi A, Irizarry MC, Duff K, Saido TC, Hsiao AK, Hasegawa M, et al. Age-related amyloid beta deposition in transgenic mice overexpressing both Alzheimer mutant presenilin 1 and amyloid beta precursor protein Swedish mutant is not associated with global neuronal loss. Am. J. Pathol. 2000;157(1):331–339
  96. Tang Y, Nyengaard JR, De Groot DM, Gundersen HJ. Total regional and global number of synapses in the human brain neocortex. Synapse. 2001;41(3):258–273
  97. Tanzi RE. The synaptic Abeta hypothesis of Alzheimer disease. Nat. Neurosci. 2005;8(8):977–979
  98. Tanzi RE, Bertram L. Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Cell. 2005;120(4):545–555
  99. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hansen LA, et al. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Annu. Rev. Physiol. 1991;30:572–580
  100. Teter B, Ashford JW. Neuroplasticity in Alzheimer's disease. J. Neurosci. Res. 2002;70(3):402–437
  101. Thinakaran G, Borchelt DR, Lee MK, Slunt HH, Spitzer L, Kim G, et al. Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron. 1996;17(1):181–190
  102. Thinakaran G, Sisodia SS, Presenilins . Alzheimer disease: the calcium conspiracy. Nat. Neurosci. 2006;9(11):1354–1355
  103. Torroja L, Packard M, Gorczyca M, White K, Budnik V. The Drosophila beta-amyloid precursor protein homolog promotes synapse differentiation at the neuromuscular junction. J. Neurosci. 1999;19(18):7793–7803
  104. Tu H, Nelson O, Bezprozvanny A, Wang Z, Lee SF, Hao YH, et al. Presenilins form ER Ca2+ leak channels, a function disrupted by familial Alzheimer's disease-linked mutations. Cell. 2006;126(5):981–993
  105. van Groen T, Kiliaan AJ, Kadish I. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice. Neurobiol. Dis. 2006;23(3):653–662
  106. Vanhecke D, Studer D, Ochs M. Stereology meets electron tomography: towards quantitative 3D electron microscopy. J. Struct. Biol. 2007;159(3):443–450
  107. Verret L, Jankowsky JL, Xu GM, Borchelt DR, Rampon C. Alzheimer's-type amyloidosis in transgenic mice impairs survival of newborn neurons derived from adult hippocampal neurogenesis. J. Neurosci. 2007;27:6771–6780
  108. West MJ. New stereological methods for counting neurons. Neurobiol. Aging. 1993;14(4):275–285
  109. West MJ. Stereological methods for estimating the total number of neurons and synapses: issues of precision and bias. Trends Neurosci. 1999;22(2):51–61
  110. West MJ, Coleman PD, Flood DG, Troncoso JC. Differences in the pattern of neuronal loss in normal aging and Alzheimer's disease. Lancet. 1994;244:769–772
  111. West MJ, Kawas CH, Stewart WF, Rudow GL, Troncoso JC. Hippocampal neurons in pre-clinical Alzheimer's disease. Neurobiol. Aging. 2004;25(9):1205–1212
  112. West MJ, Slomianka L, Gundersen HJG. Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. Anat. Rec. 1991;231:482–497
  113. Wirths O, Multhaup G, Czech C, Blanchard V, Moussaoui S, Tremp G, et al. Intraneuronal Abeta accumulation precedes plaque formation in beta-amyloid precursor protein and presenilin-1 double-transgenic mice. Neurosci. Lett. 2001;306(1/2):116–120
  114. Wirths O, Weis J, Kayed R, Saido TC, Bayer TA. Age-dependent axonal degeneration in an Alzheimer mouse model. Neurobiol. Aging. 2007;28:1689–1699
  115. Witgen BM, Grady MS, Nyengaard JR, Gundersen HJ. A new fractionator principle with varying sampling fractions: exemplified by estimation of synapse number using electron microscopy. J. Microsc. 2006;222(Pt 3):251–255

PII: S0197-4580(08)00024-9

doi: 10.1016/j.neurobiolaging.2008.01.009

Neurobiology of Aging
Volume 30, Issue 11 , Pages 1756-1776 , November 2009

Article Tools

* Image Usage & Resolution